Pfizer probably did more than any other company to help the world normalize from the pandemic, and it reaped a financial windfall from its twin Covid-19 franchise—the top-selling vaccine and the leadi...
Tag: Eli Lilly
Tanking Biotech Stocks Will Mean a Big Year for Deals. Who Could Benefit.
Nearly two years after biotechnology stocks began to tumble, executives at small and midsize companies in the space are finally accepting that share prices aren’t bouncing back anytime soon. With real...
California Sues Eli Lilly And Other Insulin Makers For Driving Up Drug Cost
Topline California is suing a group of pharmacy benefit managers and insulin manufacturers, including pharmaceutical giant Eli Lilly, for using “unlawful, unfair and deceptive” means to drive up the c...
It’s Pharma Time: Why Merck and Lilly Stock Are Buys, but not Pfizer.
My 2023 biotech outlook calls for continued momentum in name changes. I just need to figure out what the stocks will do. Last year, Respira Technologies became Qnovia. It’s run by a former tobacco exe...
Musk Issues New Rule For Parody Twitter Accounts After ‘Verified’ Impersonators Cause Chaos
Topline Twitter CEO Elon Musk on Thursday night outlined the latest set of rules under which parody accounts will operate, including clear identification, hours after multiple impersonator accounts wh...
Eli Lilly Clarifies It’s Not Offering Free Insulin After Tweet From Fake Verified Account—As Chaos Unfolds On Twitter
Topline Pharmaceutical company Eli Lilly clarified Thursday it is not offering free insulin, after a fake Twitter account—which was verified through Twitter Blue, a new subscription service implemente...
Buy Merck And Eli Lilly
Photographer: Michael Nagle/Bloomberg © 2022 Bloomberg Finance LP The coming week is post options expiration week in October. The histogram below tells us that this week has a bearish tinge. S&P 5...
An Alzheimer’s Drug’s Big Surprise: What It Means
Until this past week, there seemed to be no answers to the Alzheimer’s puzzle. The leading theory of the disease, that it was caused by a buildup of beta amyloid plaque in the brain, had been disprove...
Ups & Downs: Top Pharmaceutical Stocks Post-COVID
Who will be Big Pharma’s winners post-COVID? Getty Images There’s little argument that the COVID-19 pandemic reshaped the world. While families and governments continue to grapple with Omicron v...
Novartis Will Cut 8,000 Jobs Under CEO’s Shake-Up Plan
Text size Vasant Narasimhan, CEO of Novartis. ERIC PIERMONT/AFP/Getty Images Pharmaceutical giant Novartis said Tuesday it will lay off more than 7% of its workforce, just a few months after CEO Vas N...
Stocks Are Ready for a Bounce Higher After S&P 500 Closes Above Bear Market
Text size Dreamstime The stock market came awfully close to finishing Friday in a bear market, at least 20% off its peak in early January. Many investors would like to see it get there so Wall Street ...
Pfizer’s New CFO David Denton Negotiated One of the Biggest Healthcare Deals in History
Pfizer on Monday named a new chief financial officer with a resume that hints at the company’s plans to spend big with its Covid-19 vaccine windfall. David Denton is taking up the CFO role at Pfizer (...
U.S. Stock Futures Poised for Lower Open on Monday
Stocks are poised to open lower on Monday. Michael Nagle/Bloomberg Text size Here’s what you need to know to navigate the markets today. • U.S. stocks are set to open Monday slightly down. On Sunday n...
Biogen’s Alzheimer’s Drug Aduhelm Has Another Shot at Success
Illustration by Elias Stein Text size Biogen ’s Alzheimer’s disease therapy, Aduhelm, has been a disappointment for the company since its Food and Drug Administration approval last spring, with early ...
Buy Eli Lilly Stock. Its Obesity Drug Mounjaro Will Be a Hit, Analyst Says.
Text size Eli Lily said in August that initial demand for Mounjaro was strong. Daniel Acker/Bloomberg Eli Lilly’s novel treatment for diabetes and obesity could become one of history’s bestselling dru...